Published on 4 Jan 2022 on Simply Wall St. via Yahoo Finance

What You Need To Know About EyePoint Pharmaceuticals, Inc.'s (NASDAQ:EYPT) Investor Composition

A look at the shareholders of EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) can tell us which group is most powerful. Institutions often own shares in more established companies, while it's not unusual to see insiders own a fair bit of smaller companies. We also tend to see lower insider ownership in companies that were previously publicly owned.

With a market capitalization of US$416m, EyePoint Pharmaceuticals is a small cap stock, so it might not be well known by many institutional investors. Our analysis of the ownership of the company, below, shows that institutional investors have bought into the company. Let's delve deeper into each type of owner, to discover more about EyePoint Pharmaceuticals.

See our latest analysis for EyePoint Pharmaceuticals